News Release

加齢に伴う角膜・結膜の炎症にコンドロイチン硫酸が関与することを解明

「健康経営優良法人（ホワイト500）」に6年連続9度目の認定

Rohto Pharmaceutical Group conducts multifaceted awareness activities in conjunction with World Glaucoma Week

Development of a medical consultation recommendation evaluation index based on a survey of menstrual-associated symptoms, with menstrual pain as the main complaint

Rohto Pharmaceutical has released its "2025 Fertility White Paper." The key to solving the problem is to "gain accurate fertility knowledge early on" and "get support before you conceive a child."

From "reading" to "eating" academic papers: Tohoku University's "Academy Recipes®" and Rohto Pharmaceutical's "ROHTO RECIPE" collaboration menu now available

Announcement of strengthened collaboration with Reimei Co., Ltd. toward practical application in the field of Regenerative medicine

Launch of Rohto Alguard Epinastine Eye Drops, a new allergy eye drop containing the same active ingredient, epinastine hydrochloride, as the prescription version.

Human Life Code and Rohto Pharmaceutical Collaborate to Manufacture Investigational Products for Phase III Clinical Trials

Certified as Silver+ (Plus) by "Sports Yell Company 2026"